These results correspond with those of Segev et al. [17], who found an increased SIR of endometrial cancer in BRCA1, but not in BRCA2 GPV carriers who were followed until age 75 [SIR 1.91, 95%CI 1.06–3.19 and SIR 1.75, 95%CI 0.55–4.23, respectively]. Here, BRCA2 is linked to endometrial cancer.